Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to -$2.0 million.

  • Krystal Biotech's Other Working Capital Changes fell 13822.7% to -$2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 million, marking a year-over-year decrease of 6873.29%. This contributed to the annual value of $2.3 million for FY2025, which is 6873.29% down from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Other Working Capital Changes is -$2.0 million, which was down 13822.7% from $1.4 million recorded in Q3 2025.
  • Krystal Biotech's 5-year Other Working Capital Changes high stood at $5.3 million for Q4 2024, and its period low was -$2.0 million during Q4 2025.
  • For the 5-year period, Krystal Biotech's Other Working Capital Changes averaged around $624500.0, with its median value being $53500.0 (2023).
  • In the last 5 years, Krystal Biotech's Other Working Capital Changes surged by 196785.71% in 2023 and then plummeted by 28888.89% in 2024.
  • Krystal Biotech's Other Working Capital Changes (Quarter) stood at $1.7 million in 2021, then decreased by 4.8% to $1.6 million in 2022, then plummeted by 30.26% to $1.1 million in 2023, then skyrocketed by 362.8% to $5.3 million in 2024, then plummeted by 138.23% to -$2.0 million in 2025.
  • Its Other Working Capital Changes was -$2.0 million in Q4 2025, compared to $1.4 million in Q3 2025 and -$19000.0 in Q2 2025.